Plunkett Research Online: Innoviva Inc

INNOVIVA INC (INVA:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Innoviva, Inc. is a biopharmaceutical company with a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. It is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas in.....



Innoviva Inc
Ticker: INVA
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 650 808-6000
Fax: 650 827-8690
Address: 2000 Sierra Point Parkway
Suite 500
Brisbane, CA 94005 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
Eric d'EsparbesCEO/CFO/Chief Accounting Officer/Senior VP
Theodore WitekChief Scientific Officer/Senior VP
See More
Innoviva, Inc. is a biopharmaceutical company with a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. It is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas in.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor: Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
RELVAR/BREO ELLIPTA
ANORO ELLIPT
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: